Benjamin J Epstein

766 total citations
32 papers, 559 citations indexed

About

Benjamin J Epstein is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Benjamin J Epstein has authored 32 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 11 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Epidemiology. Recurrent topics in Benjamin J Epstein's work include Blood Pressure and Hypertension Studies (13 papers), Diabetes Treatment and Management (5 papers) and Hormonal Regulation and Hypertension (5 papers). Benjamin J Epstein is often cited by papers focused on Blood Pressure and Hypertension Studies (13 papers), Diabetes Treatment and Management (5 papers) and Hormonal Regulation and Hypertension (5 papers). Benjamin J Epstein collaborates with scholars based in United States, Antigua and Barbuda and United Kingdom. Benjamin J Epstein's co-authors include John G. Gums, Rushab Choksi, Biff F. Palmer, David Sutton, Wilmer W. Nichols, Karl Drlica, Steven M. Smith, Juwon Yim, Enrique Molina and Nancy Borja‐Hart and has published in prestigious journals such as SHILAP Revista de lepidopterología, Drugs and Current Pharmaceutical Design.

In The Last Decade

Benjamin J Epstein

31 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin J Epstein United States 15 220 212 119 104 85 32 559
Annette Bak Netherlands 15 233 1.1× 164 0.8× 106 0.9× 85 0.8× 133 1.6× 19 692
M. Dominique Ashen United States 13 226 1.0× 156 0.7× 147 1.2× 138 1.3× 43 0.5× 23 628
Alexia Piperidou Greece 7 173 0.8× 272 1.3× 121 1.0× 112 1.1× 38 0.4× 12 607
Ioanna Zografou Greece 12 133 0.6× 344 1.6× 160 1.3× 133 1.3× 53 0.6× 36 673
Martin P. Bedigian United States 9 480 2.2× 353 1.7× 97 0.8× 55 0.5× 44 0.5× 15 680
Sounira Mehri Tunisia 13 180 0.8× 114 0.5× 72 0.6× 42 0.4× 42 0.5× 50 419
Martin Kammerl Germany 17 226 1.0× 155 0.7× 132 1.1× 114 1.1× 256 3.0× 33 706
Doo Man Kim South Korea 15 97 0.4× 285 1.3× 185 1.6× 103 1.0× 23 0.3× 51 596
HIROSHI SEKINO Japan 9 222 1.0× 169 0.8× 162 1.4× 42 0.4× 54 0.6× 67 619
Petr Kujal Czechia 15 253 1.1× 240 1.1× 58 0.5× 54 0.5× 29 0.3× 34 514

Countries citing papers authored by Benjamin J Epstein

Since Specialization
Citations

This map shows the geographic impact of Benjamin J Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin J Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin J Epstein more than expected).

Fields of papers citing papers by Benjamin J Epstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin J Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin J Epstein. The network helps show where Benjamin J Epstein may publish in the future.

Co-authorship network of co-authors of Benjamin J Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin J Epstein. A scholar is included among the top collaborators of Benjamin J Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin J Epstein. Benjamin J Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Steven M., Xuerong Wen, Yan Gong, et al.. (2014). Baseline predictors of central aortic blood pressure: A PEAR substudy. Journal of the American Society of Hypertension. 8(3). 152–158. 9 indexed citations
2.
Choksi, Rushab, et al.. (2014). Tofogliflozin: A highly selective SGLT2 inhibitor for the treatmentof type 2 diabetes. Drugs of today. 50(11). 739–739. 15 indexed citations
3.
Epstein, Benjamin J, et al.. (2013). SGLT-2 inhibitors and their potential in the treatment of diabetes. Diabetes Metabolic Syndrome and Obesity. 6. 453–453. 86 indexed citations
4.
Epstein, Benjamin J, et al.. (2013). Management of hypertension with fixed-dose triple-combination treatments. Therapeutic Advances in Cardiovascular Disease. 7(5). 246–259. 16 indexed citations
5.
Epstein, Benjamin J, et al.. (2012). The evolving landscape of RAAS inhibition: from ACE inhibitors to ARBs, to DRIs and beyond. Expert Review of Cardiovascular Therapy. 10(6). 713–725. 13 indexed citations
6.
Smith, Steven M., et al.. (2011). Carvedilol Reduces Aortic Wave Reflection and Improves Left Ventricular/Vascular Coupling: A Comparison With Atenolol (CENTRAL Study). Journal of Clinical Hypertension. 13(12). 917–924. 24 indexed citations
7.
Epstein, Benjamin J. (2010). Aliskiren and valsartan combination therapy for the management of hypertension. SHILAP Revista de lepidopterología. 1 indexed citations
8.
Kuritzky, Louis, et al.. (2010). How to Obtain Appropriate Type 2 Diabetes Control in the First 180 Days of Treatment Initiation. Postgraduate Medicine. 122(3). 33–42. 3 indexed citations
9.
Epstein, Benjamin J. (2010). Improving blood pressure control rates by optimizing combination antihypertensive therapy. Expert Opinion on Pharmacotherapy. 11(12). 2011–2026. 8 indexed citations
10.
Epstein, Benjamin J, Steven M. Smith, & Rushab Choksi. (2009). Recent changes in the landscape of combination RAS blockade. Expert Review of Cardiovascular Therapy. 7(11). 1373–1384. 22 indexed citations
11.
Epstein, Benjamin J, et al.. (2009). Managing Peripheral Edema in Patients With Arterial Hypertension. American Journal of Therapeutics. 16(6). 543–553. 15 indexed citations
12.
Nichols, Wilmer W. & Benjamin J Epstein. (2009). Actions of Selected Cardiovascular Hormones on Arterial Stiffness and Wave Reflections. Current Pharmaceutical Design. 15(3). 304–320. 18 indexed citations
13.
Epstein, Benjamin J, et al.. (2009). Endothelin receptor antagonists as antihypertensives: the next frontier. Expert Review of Cardiovascular Therapy. 7(6). 675–687. 7 indexed citations
14.
Epstein, Benjamin J, et al.. (2009). Optimizing Management of Hypertension With Combination Therapy. The Journal of Cardiovascular Nursing. 24(5). 380–389. 3 indexed citations
15.
Epstein, Benjamin J, et al.. (2008). The importance of managing cardiovascular risk in the treatment of hypertension: The role of ACE inhibitors and ARBs. Journal of the American Academy of Nurse Practitioners. 20(11). 529–538. 1 indexed citations
16.
Epstein, Benjamin J, et al.. (2007). Discordant Effects of β‐Blockade on Central Aortic Systolic and Brachial Systolic Blood Pressure: Considerations Beyond the Cuff. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(9). 1322–1333. 8 indexed citations
17.
Epstein, Benjamin J, John G. Gums, Phillip J. Turner, Michael Feldgarden, & Wei Hou. (2007). Integrating Susceptibility Data from Two Surveillance Programs with Unique Methodological Techniques: The Antibiogram Resistance Method or Isolate-Based Resistance Monitoring (ARMOR) Study Group. Hospital Pharmacy. 42(5). 435–446. 1 indexed citations
18.
Epstein, Benjamin J & John G. Gums. (2005). Can the Renin‐Angiotensin System Protect Against Stroke? A Focus on Angiotensin II Receptor Blockers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(4). 531–539. 13 indexed citations
19.
Epstein, Benjamin J & John G. Gums. (2005). Optimal Pharmacological Therapy for Community-Acquired Pneumonia. Drugs. 65(14). 1949–1971. 9 indexed citations
20.
Gums, John G. & Benjamin J Epstein. (2005). Fluoroquinolone- and Methicillin-Resistant Staphylococcus Aureus: Insights from the Antimicrobial Resistance Management Program. Journal of Pharmacy Technology. 21(3). 123–128. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annette Bak Breakdown of academic impact, for papers by M. Dominique Ashen Breakdown of academic impact, for papers by Alexia Piperidou Breakdown of academic impact, for papers by Ioanna Zografou Breakdown of academic impact, for papers by Martin P. Bedigian Breakdown of academic impact, for papers by Sounira Mehri Breakdown of academic impact, for papers by Martin Kammerl Breakdown of academic impact, for papers by Doo Man Kim Breakdown of academic impact, for papers by HIROSHI SEKINO Breakdown of academic impact, for papers by Petr Kujal
Rankless by CCL
2026